Tag: Bullfrog
LIMBO-ATX trial studying Bullfrog device in critical limb ischaemia patients completes...
Mercator MedSystems has announced completion of enrolment in the company’s LIMBO-ATX (Lower-limb adventitial infusion of dexamethasone via Bullfrog to reduce occurrence of restenosis after...
DANCE data boost for dexamethasone use after revascularisation in femoropopliteal arteries
While drug-eluting devices, be they balloons or stents, use chemotherapeutic agents (usually paclitaxel) to reduce the build-up of scar tissue inside the arteries, a...
